6. CAPITAL STOCK TRANSACTIONS | 9 Months Ended |
Sep. 30, 2013 |
Equity [Abstract] | ' |
NOTE 6 - CAPITAL STOCK TRANSACTIONS | ' |
Preferred Stock |
|
On June 3, 2013, the Company filed a Certificate of Amendment of Articles of Incorporation with the State of Nevada Secretary of State giving it the authority to issue 50,000,000 shares of preferred stock with a par value of $0.0001 per share. |
|
Common Stock |
|
Between January 1, 2013 and March 31, 2013, the Company entered into a series of stock purchase agreements with accredited investors for the sale of 10,629,745 shares of its common stock. The sales closed and cash of $700,085 was received. There was no underwriter, no underwriting discounts or commissions, no general solicitation, no advertisement, and resale restrictions were imposed by placing a Rule 144 legend on the certificates. The persons who received securities have such knowledge in business and financial matters that he/she/it is capable of evaluating the merits and risks of the transaction. This transaction was exempt from registration under the Securities Act of 1933, based upon Section 4(2) for transactions by the issuer not involving any public offering. |
|
Between April 1, 2013 and June 30, 2013, the Company entered into a series of stock purchase agreements with accredited investors for the sale of 15,912,906 shares of its common stock, 2,849,639 shares had warrants attached, (see note common stock warrants below). The sales closed and cash of $650,583 was received. There was no underwriter, no underwriting discounts or commissions, no general solicitation, no advertisement, and resale restrictions were imposed by placing a Rule 144 legend on the certificates. The persons who received securities have such knowledge in business and financial matters that he/she/it is capable of evaluating the merits and risks of the transaction. This transaction was exempt from registration under the Securities Act of 1933, based upon Section 4(2) for transactions by the issuer not involving any public offering. |
|
April 16, 2013, the Company granted 400,000 shares of common stock to Benchmark Advisory as payment for marketing services. The shares were valued per the agreement at $0.05 per share for a total of $20,000, the stock was expensed $20,000 for that date and the nine months ended September 30, 2013. |
|
On June 3, 2013, the Company filed a Certificate of Amendment of Articles of Incorporation with the State of Nevada Secretary of State giving it the authority to issue 450,000,000 shares of common stock with a par value of $0.0001 per share. |
|
From July 1, 2013 to September 30, 2013, the Company granted 5,454,606 shares of common stock to various consultants for services. A compensation expense of $1,130,884 was recorded during the period ended September 30, 2013. |
|
Between July 1, 2013 and September 30, 2013, the Company entered into a series of stock purchase agreements with accredited investors for the sale of 14,286,581 shares of its common stock, 718,875 shares had warrants attached, (see note common stock warrants below). The sales closed and cash of $1,081,451 was received. There was no underwriter, no underwriting discounts or commissions, no general solicitation, no advertisement, and resale restrictions were imposed by placing a Rule 144 legend on the certificates. The persons who received securities have such knowledge in business and financial matters that he/she/it is capable of evaluating the merits and risks of the transaction. This transaction was exempt from registration under the Securities Act of 1933, based upon Section 4(2) for transactions by the issuer not involving any public offering. |
|
Common Stock Options |
|
On February 20, 2013, the Company granted 75,000 stock options to a Director, Woodrow W. Clark II, to purchase shares at $0.25 per share. The options expire February 20, 2016 and vested on the grant date. The total estimated value using the Black-Scholes Model, based on a volatility rate of 468%, expected term of 2 years, risk free rate of 0.42 percent, and a call option value of $0.17, was $12,749. As the stock options were immediately vested, the stock expensed was $12,749 on that date and for the period ended March 31, 2013. |
|
On February 20, 2013, the Company granted 75,000 stock options to a Director, Lane Harrison to purchase shares at $0.25 per share. The options expire February 20, 2016 and vested on the grant date. The total estimated value using the Black-Scholes Model, based on a volatility rate of 468%, expected term of 2 years, risk free rate of 0.42 percent, and a call option value of $0.17, was $12,749. As the stock options were immediately vested, the stock expensed was $12,749 on that date and for the period ended March 31, 2013. |
|
On April 9, 2013, the Company modified the 75,000 stock options granted to a Director, Lane Harrison on February 20, 2013, to purchase shares at $0.25 per share, the option was modified entitling Mr. Harrison to purchase 100,000 shares at $0.10, on or before April 30, 2015. The stock option provided for cashless exercise term. The total estimated value using the Black-Scholes Model, based on a volatility rate of 470%, expected term of 2 years, risk free rate of 0.42 percent, and a call option value of $0.0882, was $8,822. The stock expensed was $8,822 on that date and for the period ended September 30, 2013. |
|
On April 9, 2013, the Company modified the 75,000 stock options granted to a Director, Woodrow Clark on February 20, 2013, to purchase shares at $0.25 per share, the option was modified entitling Mr. Clark to purchase 100,000 shares at $0.10, on or before April 30, 2015. The stock option provided for cashless exercise term. The total estimated value using the Black-Scholes Model, based on a volatility rate of 470%, expected term of 2 years, risk free rate of 0.42 percent, and a call option value of $0.0882, was $8,822. The stock expensed was $8,822 on that date and for the period ended September 30, 2013. |
|
A summary of option activity as of September 30, 2013 and changes during the nine months ended is presented below: |
|
| | Number Outstanding | | | Weighted-Average Exercise Price Per Share | | | Weighted-Average Remaining Contractual Life (Years) | |
| | | | | | | | | |
Outstanding at January 1, 2013 | | | 150,000 | | | $ | 0.33 | | | | 2.5 | |
| | | | | | | | | | | | |
Granted | | | 200,000 | | | | 0.1 | | | | 1.75 | |
Exercised | | | – | | | | – | | | | – | |
Canceled/forfeited/expired | | | | | | | | | | | – | |
Outstanding at September 30, 2013 | | | 350,000 | | | $ | 0.2 | | | | 1.86 | |
| | | | | | | | | | | | |
Options vested and exercisable at September 30, 2013 | | | 350,000 | | | $ | 0.2 | | | | 1.86 | |
|
Common Stock Warrants |
|
|
Between May 24, 2013 and June 27, 2013, 2,849,639 shares of common stock were sold with warrants attached the terms of the subscription were:, for each 4 shares purchased the purchaser received 2 warrants, one warrant with a future price of $0.15 and a second warrant with a future price of $0.20, both warrants expire two years from the closing date of September 30, 2013, (1,424,819 warrants were issued 712,410 at $0.15, and 712,410 at $0.20) The total estimated value using the Black-Scholes Model, based on a volatility rate of 450%, expected term of 2 years, risk free rate of 0.38 percent, and a warrant value of $0.0449, was $63,279. |
|
From July 1, 2013 and August 14, 2013, 1,287,750 shares of common stock were sold with warrants attached. The terms of the subscription were:, for each 4 shares purchased the purchaser received 2 warrants, one warrant with a future price of $0.15 and a second warrant with a future price of $0.20, both warrants expire two years from June 30, 2013, (643,875 warrants were issued 321,937 at $0.15, and 321,938 at $0.20). From July 1, 2013 and August 14, 2013, 1,666,666 shares of common stock were sold with 75,000 warrants with an exercise price of $0.15 and 75,000 warrants with an exercise price of $0.20. |
|
A summary of non-employee warrant activity during the nine months ended as of September 30, 2013 is presented below: |
|
| | Number Outstanding | | | Weighted-Average Exercise Price Per Share | | | Weighted-Average Remaining Contractual Life (Years) | |
| | | | | | | | | |
Outstanding at January 1, 2013 | | | 450,000 | | | $ | 0.57 | | | | 2.59 | |
| | | | | | | | | | | | |
Granted | | | 2,143,694 | | | | 0.175 | | | | 1.85 | |
Exercised | | | – | | | | – | | | | – | |
Canceled/forfeited/expired | | | 450,000 | | | | 0.057 | | | | – | |
Outstanding at September 30, 2013 | | | 2,143,694 | | | $ | 0.175 | | | | 1.85 | |
| | | | | | | | | | | | |
Warrants vested and exercisable at September 30, 2013 | | | 2,143,694 | | | $ | 0.175 | | | | 1.85 | |
|